In 2023, the global hepatic markers market is expected to be worth USD 2.3 billion. The market is expected to reach USD 4.2 billion by 2033, expanding at a 6.2% CAGR throughout the forecast period. The hepatic markers market has been witnessing significant growth in recent years. The market size is influenced by growing demand for non-invasive diagnostic tools, focus on early detection & prevention & advancements in diagnostic technologies.
Liver diseases, including viral hepatitis, alcoholic liver disease, NAFLD, and liver cirrhosis, are on the rise globally. Factors such as obesity, alcohol consumption, viral infections, and lifestyle changes contribute to the growing burden of liver diseases, driving the demand for hepatic markers for early detection, disease monitoring, and personalized treatment strategies.
The demand for non-invasive diagnostic tools for liver diseases is increasing. Patients prefer non-invasive methods like blood tests, imaging techniques (e.g., ultrasound, FibroScan), and biomarker analysis to avoid the discomfort and risks associated with invasive procedures such as liver biopsies. Non-invasive hepatic markers offer convenience, safety, and accurate assessment of liver health.
There is a growing emphasis on preventive healthcare, including regular liver health screening and monitoring. Awareness campaigns, public health initiatives, and routine health check-ups have led to increased demand for hepatic markers as part of preventive care. Early detection and timely intervention help prevent disease progression and improve patient outcomes.
Technological advancements have revolutionized the hepatic markers market. Molecular diagnostics, genetic testing, proteomic analysis, and imaging modalities have improved the accuracy, sensitivity, and specificity of liver disease diagnosis. These advancements enable early detection, personalized treatment approaches, and monitoring of therapeutic response, thereby driving the demand for hepatic markers.
Key Takeaways from the Hepatic markers market:
- The hepatic markers industry in the United States is predicted to reach USD 1.1 billion by 2033, increasing at a 3.7% CAGR.
- The hepatic markers industry in the United Kingdom is estimated to reach a market value of USD 180.2 million, expanding at a CAGR of 3.8% by 2033.
- During the forecast period, the hepatic markers industry in China is expected to reach a market value of USD 241.2 million, securing a 6.4% CAGR.
- The hepatic markers industry in Japan is predicted to reach USD 177.4 million by 2033, increasing at a 6.2% CAGR.
- South Korea’s hepatic markers industry is set to rise at a 6.0% CAGR during the forecast period.
- With a CAGR of 5.6% from 2023 to 2033, Aspartate transaminase (AST) is expected to dominate the hepatic markers industry.
- With a CAGR of 5.5% from 2023 to 2033, Viral hepatitis is expected to dominate the hepatic markers industry.
- With a CAGR of 5.5% from 2023 to 2033, the hospitals is expected to dominate the hepatic markers industry.
Enhanced Market Demand: Discover Thorough Trends and Insights in Our Complete Report!
How Does the Competition Look in the Hepatic Markers Market?
The hepatic markers sector is a very competitive one, with many firms fighting for market share. Several significant participants in this industry comprise Alpha Laboratories, Biobase Group, F. Hoffmann-La Roche Ltd & ELITechGroup
The major companies are heavily spending in research & development efforts to create innovative and inventive care with enhanced effectiveness, dependability, and affordability. They are also focusing on expanding their products related to hepatic markers and strengthening their distribution methods in order to fulfil shifting consumer expectations.
Tactical alliances and partnerships with other companies are becoming more common in the industry, allowing parties to leverage one another’s strengths and expand their market influence.
Leading firms use consolidation and mergers to strengthen their market position and gain entry into new markets. The sector is expanding significantly in developing economies, particularly in India and China.
To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites. They are also concentrating on offering cost-effective tests to customers in these markets in order to get a competitive advantage.
Key Developments in the Hepatic Markers Market:
- In August 2022, Thermo Fisher Scientific Inc. to increase the size of its local medical device assembly facility and add more than 100 local employments, aims to invest $40 million.
- In December 2022, Boston Scientific Corporation made a partial offer to purchase a majority position in Acotec with up to a maximum of 65% of the company’s shares. Acotec provides various interventional procedures solutions.
Segmentation Analysis of the Hepatic Markers Market:
By Test:
- Alkaline phosphatase (ALP)
- Alanine transaminase (ALT)
- Aspartate transaminase (AST)
- Gamma-glutamyl transferase (GGT)
- Others
By Indication:
- Viral Hepatitis
- Non-alcoholic Fatty Liver Disease (NAFLD)
- Hemochromatosis
- Others
By End User:
- Hospitals
- Laboratories
- Others
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
